Lumosa Therapeutics Co., Ltd. announced a private placement to issue 70,000,000 common shares on May 31, 2023. The transaction has been approved by shareholders of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
208.5 TWD | -0.24% |
|
-3.92% | +205.27% |
May. 14 | Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 14 | Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+205.27% | 1.06B | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- 6535 Stock
- News Lumosa Therapeutics Co., Ltd.
- Lumosa Therapeutics Co., Ltd. announced a financing transaction